San Aye, Hiremagalur Balaji, Muircroft Wendy, Grealish Laurie
Gold Coast Health, Southport, QLD, Australia.
Dement Geriatr Cogn Disord. 2017;44(3-4):182-195. doi: 10.1159/000479679. Epub 2017 Sep 5.
Cognitive impairment in end-stage kidney disease patients on dialysis is increasingly common. This study aimed to review the practice of screening and to evaluate the evidence on cognitive impairment prevalence in this population.
This scoping review of studies summarises the evidence on cognitive impairment in dialysis populations. The search included the Medline, CINAHL, Embase, PsycINFO, PubMed, and Cochrane Library databases for English-language articles published between 2000 and 2015. A total of 46 articles were reviewed.
The studies were of prospective observational design, with the majority conducted in the haemodialysis population. The reported prevalence of cognitive impairment ranged from 6.6 to 51%. Three screening tools were consistently used.
While cognitive impairment is recognised in the dialysis population, there is paucity of screening data. The design of prospective comparisons ideally includes established screening instruments, particularly the Montreal Cognitive Assessment, to determine the optimal results for this population. Translation of established screening tools to increase the inclusion of people from other cultural and language groups is required. Regular screening can enhance the timing to introduce home-based care support and advance care planning discussions.
接受透析治疗的终末期肾病患者出现认知障碍的情况日益常见。本研究旨在回顾筛查实践，并评估该人群中认知障碍患病率的相关证据。
这项对研究的范围综述总结了透析人群中认知障碍的证据。检索了2000年至2015年期间发表的英文文章的Medline、CINAHL、Embase、PsycINFO、PubMed和Cochrane图书馆数据库。共审查了46篇文章。
这些研究采用前瞻性观察设计，大多数在血液透析人群中进行。报告的认知障碍患病率在6.6%至51%之间。一致使用了三种筛查工具。
虽然透析人群中的认知障碍已得到认可，但筛查数据匮乏。前瞻性比较的设计理想情况下应包括既定的筛查工具，尤其是蒙特利尔认知评估量表，以确定该人群的最佳结果。需要对既定的筛查工具进行翻译，以增加其他文化和语言群体人群的纳入。定期筛查可以提高引入居家护理支持和推进护理计划讨论的时机。
